Top Banner
Repugnance as a Market Constraint
34

Repugnance as a Market Constraint

Jan 18, 2016

Download

Documents

Rosie

Repugnance as a Market Constraint. Ewww!!!!. Prostitution. Gambling. Tradable Pollution Permits. Interest on loans. Ticket scalping. Horse meat. Smoking Marijuana. Sperm donation. Dwarf-tossing. Selling human organs. Should We Allow a Market For Transplant Organs?. Or. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Repugnance as a Market Constraint

Repugnance as a Market Constraint

Page 2: Repugnance as a Market Constraint

Ewww!!!!

Page 3: Repugnance as a Market Constraint

Prostitution

Page 4: Repugnance as a Market Constraint

Gambling

Page 5: Repugnance as a Market Constraint

Tradable Pollution Permits

Page 6: Repugnance as a Market Constraint

Interest on loans

Page 7: Repugnance as a Market Constraint

Ticket scalping

Page 8: Repugnance as a Market Constraint

Horse meat

Page 9: Repugnance as a Market Constraint

Smoking Marijuana

Page 10: Repugnance as a Market Constraint

Sperm donation

Page 11: Repugnance as a Market Constraint

Dwarf-tossing

Page 12: Repugnance as a Market Constraint

Selling human organs

Page 13: Repugnance as a Market Constraint

Should We Allow a Market For Transplant Organs?

Or. . .

Economics for JournalistsMarch 11, 2008 Dr. Norman Cloutier, DirectorUW-Parkside Center for Economic Education

Brother,

can you spare

a kidney?

Page 14: Repugnance as a Market Constraint

Kidney Transplant Background

• From the first kidney transplant in 1954, both transplants and those seeking transplants have grown over time.

• Transplants• 1990 10,000• 2005 13,700• Most of this increase came from live donors.

• Waiting list• 1990 17,000• 2006 65,000• Reasons for the increase?

– Technological advance.

– Inability of the current system to procure enough organs.

Page 15: Repugnance as a Market Constraint

• Waiting list is not a complete measure of kidney demand. In 2004, there were 50,000 on the official waiting list, but 335,000 on dialysis.

• The median waiting time for people placed on the kidney transplant waiting list is more than 3 years.

• People suffer and die while waiting for a kidney transplant:

• 1990 1,000 people died• 2005 4,000 people died

Page 16: Repugnance as a Market Constraint

• In 2004, 80% of living donors and recipients were related.

• The opportunity to buy and sell kidneys has the potential to save lives and improve the quality of life for many people.

Page 17: Repugnance as a Market Constraint

The Demand for Kidney Transplants Has Grown Faster Than the Supply

Source: Becker and Elias, 2007

Page 18: Repugnance as a Market Constraint

P

Q

$160,000

D1

S

Number of kidney transplants

To

tal c

os

t o

f k

idn

ey

tra

ns

pla

nts

Qs

Price CeilingLegal max price of kidney = $0

Market for Kidney Transplants

Qd

Page 19: Repugnance as a Market Constraint

P

Q

$160,000

D1

S

Number of kidney transplants

To

tal c

os

t o

f k

idn

ey

tra

ns

pla

nts

Qs

Price Ceiling

Market for Kidney Transplants

Qd

Waiting List

Page 20: Repugnance as a Market Constraint

P

Q

$160,000

D1

S

Number of kidney transplants

To

tal c

os

t o

f k

idn

ey

tra

ns

pla

nts

Qs

Price Ceiling

Market for Kidney Transplants

Qd

Growing Waiting List

D2

Qd

Technological advances have increased the number of patients eligible for transplantation

Page 21: Repugnance as a Market Constraint

P

Q

$160,000

S

Number of kidney transplants

To

tal c

os

t o

f k

idn

ey

tra

ns

pla

nts

Qs

Price Ceiling

Market for Kidney Transplants

D2

Qd

Page 22: Repugnance as a Market Constraint

The Market Price of a Kidney

• Monetary incentives would change the supply of kidneys from completely inelastic to highly elastic.

• The potential supply of kidneys is very large relative to the number transplants.

• The “reservation” of price of a kidney?• Risk of death• Lost time on the job• Risk of lower quality of life

Page 23: Repugnance as a Market Constraint

• Risk of Death• Reported donor death rates .03 – .06%• Assume a conservative .1% risk of death• “Value of a statistical life,” VSL= $5 million• Value of risk of death= .001 x $5 mil = $5,000

• Value of foregone earnings• VSL is derived for a person earning $35,000/year• Four weeks of recovery= $2,700

• Reduced Quality of Life• Difficult to estimate• Arbitrarily assume $7,500

Page 24: Repugnance as a Market Constraint

Reservation Price of a Kidney

Risk of death $ 5,000

Foregone earnings $ 2,700

Reduced quality of life $ 7,500

Total $15,200

Page 25: Repugnance as a Market Constraint

P

Q

$160,000

S

Number of kidney transplants

To

tal c

os

t o

f k

idn

ey

tra

ns

pla

nts

Qs

Price Ceiling

Allowing for Legal Market Transactions

D2

Qd

$175,200 S2

Q*

There would be a 9.5% increase in transplant cost, but a 44% increase in actual transplants. In 2005:

1.44 x 13,500= 19,440

Page 26: Repugnance as a Market Constraint

Not Only Saving Lives:Reduced Time on Waiting List

• Average time to graft failure increases with immediate transplant.

• Reduced pain and suffering• Employment rate of transplant patients is 15 points

higher than those on waiting list.• Measures of quality of life increase with transplant

relative to those on dialysis.

Page 27: Repugnance as a Market Constraint

Can We Increase the Supply of Cadaveric Donations?

• Presumed consent

• Public and professional education

Page 28: Repugnance as a Market Constraint

P

Q

$160,000

S

Number of kidney transplants

To

tal c

os

t o

f k

idn

ey

tra

ns

pla

nts

Qs

Presumed Consent and Supply Shift

D2

Qd

S2

Qs

Page 29: Repugnance as a Market Constraint

Objections to the Sale of Organs

• Objectification• Money changes the nature of social relationships.

• Coercion• The poor should be protected from exploitation.

• Slippery Slope• Leads to unacceptable secondary effects and to

the possible legalization of truly repulsive transactions.

Page 30: Repugnance as a Market Constraint

Objectification

• Money transforms a “good” deed into a “bad” one.

• “…any procedure which tends to commercialize human organs or to consider them as items of exchange or trade must be considered morally unacceptable, because to use the body as an ‘object’ is to violate the dignity of the human person.” Pope John Paul II, 2000

• Does the fact that the poor tend to take more dangerous, life-threatening jobs diminish their humanity?

Page 31: Repugnance as a Market Constraint

Coercion

• “It is an unethical approach to shift the tragedy from those waiting for organs to those exploited into selling them.”

• Coercion in the absence of monetary compensation?

• In Iran, the introduction of monetary compensation has reduced the non-monetary coercion of relatives.

• Is it ethical to deprive the poor of the opportunity to increase their standard of living – and save lives?

Page 32: Repugnance as a Market Constraint

Slippery Slope

• Opposition to compensation for cadaveric organs is that it will lead to live organ sales.

• More support for live donor compensation among surgeons and the general public.

• Organ theft and black market in organs?• Legalizing live organ sales will reduce the chances

of organ theft and illegal markets.

Page 33: Repugnance as a Market Constraint

P

Q

$160,000

S

Number of kidney transplants

To

tal c

os

t o

f k

idn

ey

tra

ns

pla

nts

Qs

Black Market ?

D2

Qd

$175,200 S2

Q*

ProhibitionKidney Price= $0

Black MarketKidney Price= $100,000 (?)

P*

Page 34: Repugnance as a Market Constraint

References and Further Reading

• Becker and Elias, “Introducing Incentives in the Market for Live and Cadaveric Organ Donations, Journal of Economic Perspectives 21(3), Summer 2007, p.2-24

• Howard, “Producing Organ Donors,” Journal of Economic Perspectives 21(3), Summer 2007, p. 25-36.

• Roth, “Repugnance as a Constraint on Markets,” Journal of Economic Perspectives 21(3), Summer 2007, p. 37-58.

• Teaching the Ethical Foundations of Economics, National Council on Economic Education, 2007.

• http://freakonomics.blogs.nytimes.com/2007/11/13/kidneys-for-sale/#more-2089